Table 1.
Baseline clinicopathological characteristics among 475 patients in the PALLiON study before last-line chemotherapy for pancreatic cancer (PAN) or other gastrointestinal cancers (GI).
| Characteristics | PAN (N = 189) | GI (N = 286) | p | |
|---|---|---|---|---|
| Age | Mean (±SD) | 67.7 (8.76) | 67.2 (10.24) | 0.54 |
| Sex (%) | Male | 124 (65.6) | 177 (61.9) | 0.44 |
| Female | 65 (34.4) | 109 (38.1) | ||
| PS (%) | 0–1 | 178 (94.2) | 265 (92.7) | |
| 2 | 11 (5.8) | 19 (6.6) | 0.85 | |
| 3 | 0 | 2 (0.7) | ||
| BMI 1 (%) | <18.5 | 8 (4.2) | 14 (4.9) | 0.73 |
| ≥18.5 | 181 (95.8) | 271 (94.8) | ||
| Main cancer diagnosis (%) | Pancreas | 189 (100.0) | - | NA |
| Colorectal | - | 131 (45.8) | ||
| Cholangiocarcinoma | - | 57 (19.9) | ||
| Gastric | - | 41 (14.3) | ||
| Oesophagus | - | 35 (12.2) | ||
| Rectum | - | 21 (7.3) | ||
| Liver | - | 1 (0.3) | ||
| mGPS 2 (%) | 0 | 29 (15.3) | 30 (10.4) | 0.47 |
| 1 | 56 (29.6) | 96 (33.6) | ||
| 2 | 33 (17.5) | 46 (16.1) | ||
| Albumin 3 (%) | <35 g/L | 48 (25.4) | 61 (21.3) | 0.42 |
| ≥35 g/L | 101 (53.4) | 158 (55.2) | ||
| CRP 4 (%) | ≤10 mg/L | 31 (16.4) | 30 (10.5) | 0.08 |
| >10 mg/L | 90 (47.6) | 142 (49.6) | ||
| Hospital size (%) | Large | 102 (53.9) | 149 (52.1) | 0.73 |
| Medium | 51 (2.6) | 89 (31.1) | ||
| Small | 36 (19.0) | 48 (16.8) | ||
PAN, pancreatic cancers; GI, gastro-intestinal cancers; PS, performance status; BMI, body mass index; CRP, C-reactive protein; NA, not applicable; mGPS score: 0, CRP ≤ 10; 1, CRP > 10; 2, CRP > 10 and alb < 35. Missing data on 1 BMI for 1 (0.05%) GI, 2 mGPS for 71 (43.4%) PAN and 114 (39.9%) GI, 3 albumin for 40 (21.2%) PAN and 67 (23.4%) GI, and 4 CRP for 68 (21.2%) PAN and 114 (39.8%) GI.